massive potential small cap bio with cashflow, page-114

Just had a quick look at AHZ presso and quarterly. credit to them for what they do, but what surprises me is that on face value they appear to be at a similar stage of development to RHT ( minus FDA approval). Yes they are a a bigger company atm ie revenues are about 4 fold of RHT, but their Market Cap is 20 times that of RHT!!

And from the chatter on that thread I gather people are thinking its undervalued...


So if we compared the two on revenue alone and RHT had a MC 1/4 that of AHZ we get MC = $50mill

So by comparison RHT should be valued today at 14 cents.
( 50million /350million shares)

Did I get that right?

Definately some more food for thought over the weekend.